Financing

Proceeds from (Repayments of) Short-Term Debt

Eli Lilly Proceeds from (Repayments of) Short-Term Debt increased by 443850.0% to $1.78B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 196.0%, from -$1.85B to $1.78B.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026

How to read this metric

Frequent reliance on short-term debt may indicate working capital volatility, while consistent repayment suggests strong cash flow generation.

Detailed definition

The net cash flow resulting from the issuance and repayment of short-term debt, such as commercial paper or revolving cr...

Peer comparison

Standard metric for companies with seasonal or cyclical working capital requirements.

Metric ID: financing_proceeds_from_repayments_of_short_term_debt

Historical Data

15 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q3 '24Q1 '25Q3 '25Q4 '25Q1 '26
Value-$1.00M-$1.00M-$1.00M$499.70M$1.62B-$1.50B$0.00$1.60B$4.59B-$5.20B-$3.09B-$1.85B-$4.09B-$400.00K$1.78B
QoQ Change+0.0%+0.0%>999%+223.7%-192.6%+100.0%+188.0%-213.3%+40.6%+40.2%-121.3%+100.0%>999%
YoY Change>999%-399.8%-100.0%-247.4%-293.7%+64.5%-32.4%+196.0%
Range-$5.20B$4.59B
CAGR+747.9%
Avg YoY Growth>999%
Median YoY Growth-66.2%
Current Streak2 quarters growth

Proceeds from (Repayments of) Short-Term Debt at Other Companies

Frequently Asked Questions

What is Eli Lilly's proceeds from (repayments of) short-term debt?
Eli Lilly (LLY) reported proceeds from (repayments of) short-term debt of $1.78B in Q1 2026.
How has Eli Lilly's proceeds from (repayments of) short-term debt changed year-over-year?
Eli Lilly's proceeds from (repayments of) short-term debt increased by 196.0% year-over-year, from -$1.85B to $1.78B.
What does proceeds from (repayments of) short-term debt mean?
Net cash changes from short-term borrowing and repayment.